208 related articles for article (PubMed ID: 37419924)
1. A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia.
Mohamed-Yassin MS; Rosman N; Kamaruddin KN; Miptah HN; Baharudin N; Ramli AS; Abdul-Razak S; Lai NM;
Sci Rep; 2023 Jul; 13(1):11036. PubMed ID: 37419924
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis.
Noubiap JJ; Bigna JJ; Nansseu JR; Nyaga UF; Balti EV; Echouffo-Tcheugui JB; Kengne AP
Lancet Glob Health; 2018 Sep; 6(9):e998-e1007. PubMed ID: 30103999
[TBL] [Abstract][Full Text] [Related]
4. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais JE; Huang X; Zhao JV
Drugs; 2023 Apr; 83(5):403-427. PubMed ID: 36941490
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
9. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study.
Peer N; Steyn K; Lombard C; Gaziano T; Levitt N
Eur J Prev Cardiol; 2014 Dec; 21(12):1549-56. PubMed ID: 23881149
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.
Chori B; Danladi B; Nwakile P; Okoye I; Abdullahi U; Zawaya K; Essien I; Sada K; Nwegbu M; Ogedengbe J; Aje A; Isiguzo G; Odili A
Cardiovasc J Afr; 2022 Mar-Apr 23; 33(2):52-59. PubMed ID: 34779815
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials.
Wu L; Ma D; Walton-Moss B; He Z
Menopause; 2014 Jan; 21(1):89-99. PubMed ID: 23736858
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
[TBL] [Abstract][Full Text] [Related]
13. Effects of very low-carbohydrate ketogenic diets on lipid profiles in normal-weight (body mass index < 25 kg/m2) adults: a meta-analysis.
Joo M; Moon S; Lee YS; Kim MG
Nutr Rev; 2023 Oct; 81(11):1393-1401. PubMed ID: 36931263
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.
Masilela C; Adeniyi OV; Benjeddou M
Sci Rep; 2022 Jan; 12(1):337. PubMed ID: 35013433
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa.
Omodanisi EI; Tomose Y; Okeleye BI; Ntwampe SKO; Aboua YG
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255455
[TBL] [Abstract][Full Text] [Related]
17. Effects of α-linolenic acid intake on blood lipid profiles：a systematic review and meta-analysis of randomized controlled trials.
Yue H; Qiu B; Jia M; Liu W; Guo XF; Li N; Xu ZX; Du FL; Xu T; Li D
Crit Rev Food Sci Nutr; 2021; 61(17):2894-2910. PubMed ID: 32643951
[TBL] [Abstract][Full Text] [Related]
18. The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.
Manosroi W; Phudphong P; Atthakomol P; Phimphilai M
BMC Endocr Disord; 2022 Aug; 22(1):217. PubMed ID: 36045354
[TBL] [Abstract][Full Text] [Related]
19. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
20. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
